Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter‐related infection treated with amikacin

Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter‐related infection treated with amikacin

Abstract The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentr...

Full description

Bibliographic Details
Main Authors: Sanae Kojya, Hideo Shiohira, Yoshitsugu Sunagawa, Shoji Tsuneyoshi, Kentaro Kohagura, Yusuke Ohya, Fusako Yonaha, Nobuo Hokama, Katsunori Nakamura
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical Case Reports
Subjects:
amikacin
nontuberculous mycobacterium
peritoneal dialysis
therapeutic drug monitoring
Online Access:https://doi.org/10.1002/ccr3.2774

Similar Items

Similar Items